Table 1.
Baseline Characteristics
| Characteristic | Elective (N=1741) | Urgent (N=429) | Total (N=2170) | P Value |
|---|---|---|---|---|
| Age, mean±SD, y | 81.9±7.2 | 81.3±8.9 | 81.8±7.6 | 0.15 |
| Sex, female | 804 (46.2) | 192 (44.8) | 996 (45.9) | 0.60 |
| Income quintile | 0.03 | |||
| 1 | 277 (15.9) | 69 (16.1) | 346 (15.9) | |
| 2 | 350 (20.1) | 103 (24) | 453 (20.9) | |
| 3 | 369 (21.2) | 85 (19.8) | 454 (20.9) | |
| 4 | 360 (20.7) | 96 (22.4) | 456 (21.0) | |
| 5 | 379 (21.8) | 73 (16.6) | 450 (20.7) | |
| Rural resident | 189 (10.9) | 68 (15.9) | 257 (11.8) | 0.004 |
| Charlson score, mean±SD | 1.81±1.86 | 2.31±2.05 | 1.91±1.91 | <0.001 |
| Dyslipidemia | 1168 (67.1) | 255 (59.4) | 1423 (65.6) | 0.003 |
| Dementia | 122 (7) | 38 (8.9) | 160 (7.4) | 0.19 |
| DM | 780 (44.8) | 211 (49.2) | 991 (45.7) | 0.10 |
| Hypertension | 1644 (94.4) | 395 (92.1) | 2039 (94.0) | 0.07 |
| HF | 1207 (69.3) | 357 (83) | 1563 (72.0) | <0.001 |
| COPD | 618 (35.5) | 159 (37.1) | 777 (35.8) | 0.54 |
| Malignancy | 118 (6.8) | 23 (5.4) | 141 (6.5) | 0.29 |
| Renal disease | 168 (9.6) | 75 (17.5) | 243 (11.2) | <0.001 |
| Dialysis | 51 (2.9) | 22 (5.1) | 73 (3.4) | 0.02 |
| CAD | 1280 (73.5) | 257 (59.9) | 1537 (70.8) | <0.001 |
| Cardiac arrhythmia/AF | 442 (25.4) | 137 (31.9) | 579 (26.7) | 0.006 |
| CVD | 93 (5.3) | 23 (5.4) | 116 (5.3) | 0.99 |
| Lung disease | 23 (1.3) | 6 (1.4) | 29 (1.3) | 0.9 |
| PVD | 94 (5.4) | 25 (5.8) | 119 (5.5) | 0.73 |
| Frailty* | 351 (20.2) | 103 (24.2) | 454 (20.9) | 0.08 |
| Previous PCI | 617 (35.4) | 121 (28.2) | 738 (34.0) | 0.005 |
| Previous CABG | 424 (24.4) | 97 (22.6) | 521 (24.0) | 0.45 |
| Previous valve surgery | 184 (10.6) | 74 (17.2) | 258 (11.9) | <0.001 |
| TAVR procedure | ||||
| Transfemoral | 1420 (81.6) | 352 (82.1) | 1772 (81.7) | 0.60 |
| Valve in valve | 147 (8.4) | 63 (14.7) | 210 (9.7) | <0.001 |
Data are given as number (percentage) of each group, unless otherwise indicated. AF indicates atrial fibrillation; CABG, coronary artery bypass graft; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease; DM, diabetes mellitus; HF, heart failure; PCI, percutaneous coronary intervention; PVD, peripheral vascular disease; TAVR, transcatheter aortic valve replacement.
*
Frailty was determined using the John Hopkins Adjusted Clinical Group Case‐Mix adjustment system (The Johns Hopkins ACG System, version 10).